Transcription profiling of human medullary thyroid carcinoma cell line TT sunitinib or vehicle treatment time course

ABSTRACT: The aim of the study was to identify major gene expression changes associated to sunitinib response in a human medullary thyroid carcinoma (MTC)ﾠmodel.ﾠWe developed an in vitro kinetic microarray study. The humanﾠﾠMTC cell line, the TT cells, were treated with 250 nM sunitinib or vehicle during 1, 3 and 6 days. Total mRNA from sunitinib treated cells were compared to placebo treated ones for each time point.

ORGANISM(S): Homo sapiens

SUBMITTER:  

PROVIDER: E-TABM-929 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress